International Clinical Trial: The clinical efficacy of VHAG regimen in the treatment of adult de novo T/myeloid mixed phenotype acute leukemia

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114769) titled 'The clinical efficacy of VHAG regimen in the treatment of adult de novo T/myeloid mixed phenotype acute leukemia' on Dec. 17, 2025.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The First Affiliated Hospital, College of Medicine, Zhejiang University

Condition: T/myeloid mixed phenotype acute leukemia

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2025-09-26

Target Sample Size: Experimental Group:10;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=289443

Published by HT Digital Content Services wi...